Stock VTI VISIONEERING TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E.
Other stock markets
 01:52:47 2024-05-02 am EDT 		5-day change 1st Jan Change
0.096 AUD -4.00% Intraday chart for Visioneering Technologies, Inc. -45.14% -61.60%
Apr. 24 Transcript : Visioneering Technologies, Inc., Q1 2024 Earnings Call, Apr 23, 2024
Feb. 28 Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 27.14 14.56 19.11 14.99 8.538 8.788
Enterprise Value (EV) 1 19.86 15.8 20.78 6.861 5.049 6.002
P/E ratio -1.41 x -0.94 x -1.55 x -5.6 x -1.18 x -1.71 x
Yield - - - - - -
Capitalization / Revenue 8.24 x 2.54 x 3.74 x 2.1 x 1.17 x 1.01 x
EV / Revenue 6.03 x 2.76 x 4.07 x 0.96 x 0.69 x 0.69 x
EV / EBITDA -1.18 x -1.25 x -2.71 x -0.95 x -0.87 x -1.51 x
EV / FCF -2.11 x -2.04 x -10.5 x -1.04 x -1.14 x -2.28 x
FCF Yield -47.4% -49.1% -9.57% -95.9% -87.8% -43.9%
Price to Book 3.03 x 14.8 x -11.2 x 1.49 x 1.36 x 1.56 x
Nbr of stocks (in thousands) 2,483 3,991 9,937 23,636 31,329 51,294
Reference price 2 10.93 3.648 1.923 0.6343 0.2725 0.1713
Announcement Date 2/18/19 2/13/20 2/17/21 2/23/22 2/27/23 2/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.294 5.722 5.105 7.154 7.285 8.67
EBITDA 1 -16.84 -12.59 -7.658 -7.239 -5.773 -3.963
EBIT 1 -16.92 -12.66 -7.712 -7.268 -5.797 -3.99
Operating Margin -513.51% -221.2% -151.07% -101.59% -79.57% -46.02%
Earnings before Tax (EBT) 1 -16.74 -12.61 -9.236 -2.329 -5.848 -3.447
Net income 1 -16.74 -12.62 -9.239 -2.334 -5.854 -3.451
Net margin -508.04% -220.5% -180.98% -32.63% -80.36% -39.8%
EPS 2 -7.754 -3.891 -1.239 -0.1134 -0.2301 -0.1000
Free Cash Flow 1 -9.417 -7.756 -1.988 -6.577 -4.431 -2.636
FCF margin -285.87% -135.55% -38.94% -91.93% -60.83% -30.4%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/18/19 2/13/20 2/17/21 2/23/22 2/27/23 2/28/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 1.24 1.67 - - -
Net Cash position 1 7.28 - - 8.13 3.49 2.79
Leverage (Debt/EBITDA) - -0.0984 x -0.2174 x - - -
Free Cash Flow 1 -9.42 -7.76 -1.99 -6.58 -4.43 -2.64
ROE (net income / shareholders' equity) -119% -254% 2,556% -56% -71.7% -57.3%
ROA (Net income/ Total Assets) -68.4% -97.6% -89.1% -45.7% -30.2% -29.8%
Assets 1 24.48 12.93 10.37 5.113 19.41 11.59
Book Value Per Share 2 3.610 0.2500 -0.1700 0.4200 0.2000 0.1100
Cash Flow per Share 2 2.930 0.4800 0.2400 0.4600 0.1000 0.0600
Capex 1 0.01 0 0 - - -
Capex / Sales 0.3% 0.02% 0.02% - - -
Announcement Date 2/18/19 2/13/20 2/17/21 2/23/22 2/27/23 2/28/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
VISIONEERING TECHNOLOGIES, INC. Stock Visioneering Technologies, Inc.
-61.60% 3.58M
ESSILORLUXOTTICA Stock EssilorLuxottica
+10.74% 96.96B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-5.14% 17.82B
AUTEK CHINA INC. Stock Autek China Inc.
-16.61% 2.33B
WARBY PARKER INC. Stock Warby Parker Inc.
-12.77% 1.42B
PEGAVISION CORPORATION Stock Pegavision Corporation
+32.16% 1.26B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-34.97% 755M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-36.42% 737M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.58% 666M
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+25.66% 501M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. VTI Stock
  4. Financials Visioneering Technologies, Inc.